Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 6,279 | 12,186 | 7,040 | 1,844 | 2,664 |
| Operating Income | -6,279 | -12,186 | -7,040 | -1,844 | -2,664 |
| Interest Expense | 3,224 | 859 | 216 | 6 | 23 |
| Other Income | -10,671 | -22,015 | 6,100 | 69 | 25 |
| Pre-tax Income | -20,173 | -35,060 | -1,155 | -1,781 | -2,662 |
| Net Income Continuous | -20,173 | -35,060 | -1,155 | -1,781 | -2,662 |
| Net Income | $-20,173 | $-35,060 | $-1,155 | $-1,781 | $-2,662 |
| EPS Basic Total Ops | -11.77 | -22.60 | -1.03 | -1.40 | -2.57 |
| EPS Basic Continuous Ops | -11.78 | -22.60 | -1.02 | -1.42 | -2.57 |
| EPS Diluted Total Ops | -11.77 | -22.60 | -1.03 | -1.40 | -2.57 |
| EPS Diluted Continuous Ops | -11.78 | -22.60 | -1.02 | -1.42 | -2.57 |
| EPS Diluted Before Non-Recurring Items | -11.77 | -22.60 | -0.80 | -1.40 | -2.60 |
| EBITDA(a) | $-6,259 | $-12,166 | $-7,036 | $-1,843 | $-2,664 |